The global biocompatible coatings market size is projected to grow from USD 14.6 billion in 2022 to USD 29.7 billion by 2028, at a CAGR of 12.4%. The demand for biocompatible coatings is influenced by several factors. One crucial factor is the increasing focus on healthcare and medical advancements. With the continuous progress in medical technology and the growing emphasis on patient well-being, there is a higher demand for biocompatible coatings in various applications. These coatings play a vital role in enhancing the biocompatibility of medical devices, implants, and prosthetics, reducing the risk of adverse reactions and improving patient outcomes. The aging population and the prevalence of chronic diseases drive the demand for medical devices and implants, which, in turn, fuels the demand for biocompatible coatings. The companies have adopted various strategies, such as mergers & acquisitions, investment & expansion, joint ventures, & new product launches and to increase their global presence and maintain sustained growth in the biocompatible coatings market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32624649
Asia Pacific, comprising countries such as China, Japan, India, South Korea, and Southeast Asian nations, is witnessing rapid industrialization, urbanization, and economic growth. This development has led to increased investments in healthcare infrastructure and medical advancements, driving the demand for biocompatible coatings. The region’s large population, particularly the aging demographic, further fuels the need for medical devices, implants, and prosthetics, which require biocompatible coatings to ensure compatibility and performance.
The Middle East, countries such as the United Arab Emirates (UAE), Saudi Arabia, and Qatar have been investing heavily in healthcare infrastructure and medical tourism. These nations are becoming regional hubs for medical treatments and procedures, attracting patients from around the world. Consequently, the demand for biocompatible coatings in the Middle East is driven by the need for high-quality medical devices, implants, and prosthetics that meet international standards.
The major players in the global biocompatible coatings market are SurModics, Inc. (US), DSM Biomedical (US), Hydromer Inc. (US), Covalon Technologies Ltd. (Canada), and Hemoteq AG (Germany). These players opted for inorganic growth through mergers & acquisitions, agreements, and partnerships. For instance, in July 2021, SurModics, Inc. has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous clot removal solutions.
SurModics, Inc: SurModics, Inc. is a global provider of surface modification and in vitro diagnostic technologies. The company is headquartered in Eden Prairie, Minnesota, United States. SurModics has been operating for over four decades and has established itself as a leader in the field of biocompatible coatings and surface modification technologies. The company’s core focus is on developing and commercializing innovative solutions that enhance the performance, biocompatibility, and functionality of medical devices. SurModics offers a broad portfolio of biocompatible coatings designed to address various applications and industries, including cardiovascular, ophthalmology, neurology, and in-vitro diagnostics. SurModics’ biocompatible coatings provide functionalities such as lubricity, hydrophilicity, drug delivery, anti-thrombogenicity, and bioactive capabilities. These coatings are tailored to meet the specific requirements of medical devices, ensuring improved performance, reduced complications, and enhanced patient outcomes. SurModics collaborates with medical device manufacturers, pharmaceutical companies, and diagnostic testing laboratories to develop customized coating and surface modification solutions. The company’s team of scientists and engineers work closely with customers to understand their specific needs and deliver innovative solutions that address their challenges.
In April 2020, Cook Medical and Surmodics, Inc. have announced a new distribution agreement in which Cook Medical will market two novel Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that may be utilised beyond 0.014-inch and 0.018-inch wire guides.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=32624649
DSM Biomedical: DSM Biomedical is a division of DSM, a global science-based company headquartered in the Netherlands. DSM Biomedical specializes in developing and manufacturing biomedical materials and technologies, with a focus on providing innovative solutions for the medical device and healthcare industries. The company offers a wide range of products and solutions that address various medical applications, including orthopedics, cardiovascular devices, dental applications, drug delivery systems, and wound care. DSM Biomedical’s expertise lies in developing biocompatible materials, coatings, drug delivery systems, and regenerative solutions that enhance the performance, biocompatibility, and safety of medical devices. The company places a strong emphasis on sustainability and environmental responsibility. DSM Biomedical strives to develop materials and technologies that are eco-friendly and have minimal impact on the environment. This commitment aligns with the growing demand for sustainable solutions in the medical industry.
In January 2021, DSM Biomedical and NC Biomatrix sign Memorandum of Understanding for the development of breakthrough regenerative devices for the treatment of back pain.
Read Our Trending Press Release Below:
Mosquito Repellent Market – Global Forecast to 2026
Aluminum Casting Market– Global Forecast to 2026
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Aashish MehraEmail: Send EmailPhone: 18886006441Address:630 Dundee Road Suite 430City: NorthbrookState: IL 60062Country: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/biocompatible-coating-market-32624649.html
